Literature DB >> 28676345

A six-month longitudinal evaluation significantly improves accuracy of predicting incipient Alzheimer's disease in mild cognitive impairment.

Asim M Mubeen1, Ali Asaei1, Alvin H Bachman1, John J Sidtis2, Babak A Ardekani3.   

Abstract

RATIONALE AND
OBJECTIVES: Early prediction of incipient Alzheimer's disease (AD) dementia in individuals with mild cognitive impairment (MCI) is important for timely therapeutic intervention and identifying participants for clinical trials at greater risk of developing AD. Methods to predict incipient AD in MCI have mostly utilized cross-sectional data. Longitudinal data enables estimation of the rate of change of variables, which along with the variable levels have been shown to improve prediction power. While some efforts have already been made in this direction, all previous longitudinal studies have been based on observation periods longer than one year, hence limiting their practical utility. It remains to be seen if follow-up evaluations within shorter intervals can significantly improve the accuracy of prediction in this problem. Our aim was to determine the added value of incorporating 6-month longitudinal data for predicting progression from MCI to AD.
MATERIALS AND METHODS: Using 6-months longitudinal data from 247 participants with MCI, we trained two Random Forest classifiers to distinguish between progressive MCI (n=162) and stable MCI (n=85) cases. These models utilized structural MRI, neurocognitive assessments, and demographic information. The first model (cross-sectional) only used baseline data. The second model (longitudinal) used data from both baseline and a 6-month follow-up evaluation allowing the model to additionally incorporate biomarkers' rate of change.
RESULTS: The longitudinal model (AUC=0.87; accuracy=80.2%) performed significantly better (P<0.05) than the cross-sectional model (AUC=0.82; accuracy=71.7%).
CONCLUSION: Short-term longitudinal assessments significantly enhance the performance of AD prediction models.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Atrophy; Corpus callosum; Hippocampus; Longitudinal analysis; MRI; Mild cognitive impairment; Prediction; Random forest classification

Mesh:

Substances:

Year:  2017        PMID: 28676345     DOI: 10.1016/j.neurad.2017.05.008

Source DB:  PubMed          Journal:  J Neuroradiol        ISSN: 0150-9861            Impact factor:   3.447


  5 in total

1.  Transfer learning-trained convolutional neural networks identify novel MRI biomarkers of Alzheimer's disease progression.

Authors:  Yi Li; Annat Haber; Christoph Preuss; Cai John; Asli Uyar; Hongtian Stanley Yang; Benjamin A Logsdon; Vivek Philip; R Krishna Murthy Karuturi; Gregory W Carter
Journal:  Alzheimers Dement (Amst)       Date:  2021-05-14

2.  Creation of an anthropomorphic CT head phantom for verification of image segmentation.

Authors:  Robin B Holmes; Ian S Negus; Sophie J Wiltshire; Gareth C Thorne; Peter Young
Journal:  Med Phys       Date:  2020-03-31       Impact factor: 4.071

3.  Longitudinal analysis of brain structure using existence probability.

Authors:  Norihide Maikusa; Tadanori Fukami; Hiroshi Matsuda
Journal:  Brain Behav       Date:  2020-10-09       Impact factor: 2.708

4.  Systematic literature review of machine learning methods used in the analysis of real-world data for patient-provider decision making.

Authors:  Alan Brnabic; Lisa M Hess
Journal:  BMC Med Inform Decis Mak       Date:  2021-02-15       Impact factor: 2.796

Review 5.  Harnessing repeated measurements of predictor variables for clinical risk prediction: a review of existing methods.

Authors:  Lucy M Bull; Mark Lunt; Glen P Martin; Kimme Hyrich; Jamie C Sergeant
Journal:  Diagn Progn Res       Date:  2020-07-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.